add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
UPDATE 1-Bioniche gets $6 mln milestone payment from Endo PharmaReuters - - Nov 6, 2009 TO) said it received the first milestone payment of $6 million under a licensing deal with Endo Pharmaceuticals (ENDP.O) for its experimental bladder cancer ... Bioniche Life Sciences Q1 loss widens to $6.8M from $3.3 as sales dip The Canadian Press Bioniche Reports Fiscal 2010 First Quarter Results And Achievement of First ... Canada NewsWire (press release) Beerman will lead RXi PharmaceuticalsBoston Globe - Nov 6, 2009 ... as executive vice president and chief business officer for Indevus Pharmaceuticals Inc., which was acquired by Endo Pharmaceuticals in March, RXi said. ... RXi Pharmaceuticals names Noah Beerman president and CEO Behavioral Health Central (blog) Beerman takes CEO post at RXi Pharmaceuticals Mass High Tech RXi Pharmaceuticals Appoints Noah D. Beerman as CEO Business Wire (press release) Penwest Pharmaceuticals Co. Q3 2009 Earnings Call TranscriptSeeking Alpha (blog) - Nov 5, 2009 Maximizing the value of Opana ER with our partner Endo Pharmaceuticals; Advancing the development of A0001, our promising compound for mitochondrial ... Endo Pharmaceuticals Holdings Inc. - SWOT Analysis - Aarkstore EnterprisePRMinds (press release) - Nov 5, 2009 Endo Pharmaceuticals Holdings - SWOT Analysis company profile is the essential source for top-level company data and information. ... Bioniche Receives $6M Milestone Payment for Bladder Cancer DrugOneMedPlace (blog) - 12 hours ago Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and ...Reuters - Oct 29, 2009 About Endo Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic ... UPDATE 1-FDA delays Endo's testosterone gel approvalReuters - - Oct 19, 2009 Oct 19 (Reuters) - US health regulators delayed approval for Endo Pharmaceuticals Holdings Inc's (ENDP.O) Fortesta, a gel used to treat testosterone ... Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM) PipelineReview.com (press release) Endo Pharmaceuticals (ENDP) Receives Complete Response From FDA On FORTESTA StreetInsider.com (subscription) Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)Reuters - Oct 19, 2009 Partnerships in Clinical Trials Expands Its Global ReachReuters - Nov 2, 2009 Notable speakers include: * Tom Daschle, Former Senate Majority and Minority Leader, US Senate * David Holveck, President and CEO, Endo Pharmaceuticals ... SADIF Analytics releases new summary due diligence report for Endo PharmaceuticalsPR-Inside.com (Pressemitteilung) - Oct 28, 2009 2009-10-28 14:41:37 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Endo Pharmaceuticals and produced a report, ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
